(Reuters) -Luxury carmaker Aston Martin lowered its profit view on Wednesday due to "evolving and disruptive" U.S. tariffs, ...

AstraZeneca's efforts are paying off as strong U.S. demand, and robust sales of newer cancer, heart and kidney disease ...